Abstract
Background The current surgical management of Neovascular Glaucoma (NVG) is with the placement of the Ahmed Valve. However, up to 70% fail and the factors associated with this failure are unknown. Recognizing the factors associated with dysfunction will help to identify patients prone to failure promptly to establish prompt management and improve visual and functional prognosis.
Objective To determine the risk factors associated with Ahmed valve dysfunction in patients with NVG during the first year after surgery.
Population Patients diagnosed with VNG who have undergone Ahmed valve implantation in the Glaucoma - APEC service, during the 2013 to 2019 period.
Methods ambispective cohort. Patients with NVG defined as the Presence of neovessels in the iris or angle of the anterior chamber were included, those who had a history of implantation of a drainage device, and patients with a diagnosis of glaucoma in the terminal phase, worse visual acuity of perception were excluded. of light. The research unit was eyes subjected to Ahmed valve implantation. The demographic characteristics of the patients were evaluated, as well as the characteristics of the eyes.
The primary outcome and the secondary outcomes were adverse events, visual acuity, and final intraocular pressure. An unadjusted Cox proportional hazards model was used to determine risk factors such as Hazzard ratios (HR). Those significant factors were included in a Cox proportional hazards model to adjust for the main confounding variables.
Results 174 eyes were included. Baseline intraocular pressure (IOP) was 46.03 (±11.8) mmHG. Baseline VA in LogMAR was 1.52(0.89-2.3). Risk factors were: Age <50 years with HR 1.54(95% CI 1.04-2.30); HB1Ac >8% HR 1.71 (95% CI 1.12-2.60) and presence hypertensive phase HR 3.13 (95% CI 1.57-6.23). The multivariate model was adjusted for the following variables, baseline IOP less than 40mmHg HR 1.60 (95% CI 1.04-2.47); HB1Ac >8% HR 1.80 (95% CI 1.16-2.78); FP7 valve type HR 1.75(95% CI 1.04-2.94) and presence of hypertensive phase HR 3.24 (95% CI 1.60-6.59).
Conclusion Basal IOP less than 40mmHg, HB1Ac >8%, type of FP7 valve, surgery performed by a resident, lack of photocoagulation after implantation, and the presence of a hypertensive phase are the independent risk factors for implant valvular dysfunction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Asociacion para evitar la ceguera en Mexico gave ethical approval for this work under the protocol number GL-20-02.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
